Bronchoscopic aspects of renal cell carcinoma (RCC)

被引:0
作者
Dobbertin, I
Dierkesmann, R
Kwiatkowski, J
Reichardt, W
机构
[1] Klin Pneumol & Thoraxchirurg, Klin Schillerhohe, D-70839 Gerlingen, Germany
[2] Klin Pneumol & Thoraxchirurg, Klin Schillerhohe, D-70839 Gerlingen, Germany
[3] Katharinenhosp, Radiol Klin, D-70174 Stuttgart, Germany
关键词
renal cell carcinoma; bronchoscopic tumor treatment; endobronchial brachytherapy; angiography of bronchial artery; haemoptysis; metastatic bronchopulmonay tumors;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A symposium on RCC in July 1998 in Tubingen was where we to reviewed our patients with endobronchial metastatic RCC treated by bronchoscopy since 1981. 24 of 26 consecutive cases are the subject of the present study. Tumor history, X-ray findings, endobronchial appearance, treatment and the pathogenetic mechanisms of this special form of metastatic spread are demonstrated and discussed. In 5 patients > 10 years relapsed between nephrectomy and bronchoscopic tumor therapy. A thrombuslike tumor growth and bleeding were striking bronchoscopic features. In X-my besides atelectasis, hilar or mediastinal masses were seen half of the patients, in 50% without parenchymal lung nodes, suggesting lymphogenic spread In several patients bronchial recanalisation could be successfully repeated over long periods. Abnormal X-ray, haemoptysis or dyspnoa in patients with RCC demands bronchoscopy. In case of bronchial tumor obstruction bronchoscopic treatment offers excellent palliation.
引用
收藏
页码:1567 / 1572
页数:6
相关论文
共 50 条
  • [31] Eosinophilic Solid and Cystic Renal Cell Carcinoma (ESC RCC) Further Morphologic and Molecular Characterization of ESC RCC as a Distinct Entity
    Trpkov, Kiril
    Abou-Ouf, Hatem
    Hes, Ondrej
    Lopez, Jose I.
    Nesi, Gabriella
    Comperat, Eva
    Sibony, Mathilde
    Osunkoya, Adeboye O.
    Zhou, Ming
    Gokden, Neriman
    Leroy, Xavier
    Berney, Daniel M.
    Cunha, Isabela Werneck
    Musto, Maria L.
    Athanazio, Daniel A.
    Yilmaz, Asli
    Donnelly, Bryan
    Hyndman, Eric
    Gill, Anthony J.
    McKenney, Jesse K.
    Bismar, Tarek A.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2017, 41 (10) : 1299 - 1308
  • [32] ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey
    Dog, Kutsal
    Onder, Evrim
    PATHOLOGY RESEARCH AND PRACTICE, 2024, 253
  • [33] CT-based radiomics model for the prediction of genomic alterations in renal cell carcinoma (RCC)
    Ebrahimi, Hedyeh
    Lu, Kun-Han
    Castro, Daniela V.
    Mercier, Benjamin D.
    Dizman, Nazli
    Barragan-Carrillo, Regina
    Govindarajan, Ameish
    Meza, Luis
    Chawla, Neal S.
    Hsu, Joann
    Chehrazi-Raffle, Alexander
    Tripathi, Abhishek
    Liu, Sandy
    Dorff, Tanya B.
    Wong, Chi Wah
    Pal, Sumanta K.
    Zengin, Zeynep B.
    ONCOLOGIST, 2023, 28
  • [34] Best treatment options for advanced renal cell carcinoma (RCC) patients: a Delphi consensus study
    Luis Perez-Gracia, Jose
    Castellano, Daniel
    Angel Climent, Miguel
    Mellado, Begona
    Suarez, Cristina
    MEDICAL ONCOLOGY, 2019, 36 (03)
  • [35] ALK rearrangements-associated renal cell carcinoma (RCC) with unique pathological features in an adult
    Jeanneau, Marie
    Gregoire, Valerie
    Desplechain, Claude
    Escande, Fabienne
    Tica, Dan Petre
    Aubert, Sebastien
    Leroy, Xavier
    PATHOLOGY RESEARCH AND PRACTICE, 2016, 212 (11) : 1064 - 1066
  • [36] Adjuvant interferon alpha therapy in renal cell carcinoma (RCC):: Prognostic value of DNA cytophotometry
    Basting, R
    Corvin, S
    Händel, D
    Hinke, A
    Schmidt, D
    ANTICANCER RESEARCH, 1999, 19 (2C) : 1493 - 1495
  • [37] The emerging role of targeted therapy in renal cell carcinoma (RCC): Is it time for a neoadjuvant or an adjuvant approach?
    Sciarra, Alessandro
    Cattarino, Susanna
    Salciccia, Stefano
    Alfarone, Andrea
    Gentilucci, Alessandro
    Parente, Ulderico
    Mariotti, Gianna
    Innocenzi, Michele
    Gentile, Vincenzo
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 81 (02) : 151 - 162
  • [38] Best treatment options for advanced renal cell carcinoma (RCC) patients: a Delphi consensus study
    José Luis Pérez-Gracia
    Daniel Castellano
    Miguel Ángel Climent
    Begoña Mellado
    Cristina Suárez
    Medical Oncology, 2019, 36
  • [39] Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC)
    Silberstein, Jonathan L.
    Adamy, Ari
    Maschino, Alexandra C.
    Ehdaie, Behfar
    Garg, Tullika
    Favaretto, Ricardo L.
    Ghoneim, Tarek P.
    Motzer, Robert J.
    Russo, Paul
    BJU INTERNATIONAL, 2012, 110 (09) : 1276 - 1282
  • [40] Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical, Pathologic, and Outcome Features Compared With RCC in the General Population
    Neuzillet, Yann
    Tillou, Xavier
    Mathieu, Romain
    Long, Jean-Alexandre
    Gigante, Marc
    Paparel, Philippe
    Poissonnier, Laura
    Baumert, Herve
    Escudier, Bernard
    Lang, Herve
    Rioux-Leclercq, Nathalie
    Bigot, Pierre
    Bernhard, Jean-Christophe
    Albiges, Laurence
    Bastien, Laurence
    Petit, Jacques
    Saint, Fabien
    Bruyere, Franck
    Boutin, Jean-Michel
    Brichart, Nicolas
    Karam, Georges
    Branchereau, Julien
    Ferriere, Jean-Marie
    Wallerand, Herve
    Barbet, Sebastien
    Elkentaoui, Hicham
    Hubert, Jacques
    Feuillu, Benoit
    Theveniaud, Pierre-Etienne
    Villers, Arnauld
    Zini, Laurent
    Descazeaux, Aurelien
    Roupret, Morgan
    Barrou, Benoit
    Fehri, Karim
    Lebret, Thierry
    Tostain, Jacques
    Terrier, Jean-Etienne
    Terrier, Nicolas
    Martin, Lucille
    Dugardin, Fabrice
    Galliot, Ismaël
    Staerman, Frederic
    Azemar, Marie-Dominique
    Irani, Jacques
    Tisserand, Baptiste
    Timsit, Marc-Olivier
    Sallusto, Federico
    Rischmann, Pascal
    Guy, Laurent
    EUROPEAN UROLOGY, 2011, 60 (02) : 366 - 373